genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
Bayer Approach to Partnerships, Pipelines, and Platforms
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
Circulating Tumor Cell
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Biomarkers
Guardant Health Launches Early-Stage Colorectal Cancer ctDNA Assay
GEN Edge
EY Firepower Report: Biopharma M&A Poised to Rebound in 2021
News
Antisense
Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma
Drug Discovery
Novel Promising Anti-Fungal Compound Identified in Ant Nests
Cancer
Promising Triple Therapy Approach Identified for Renal Cell Carcinoma
Neuroscience
Deep Sleep Aids in Neurodegenerative Disease Prevention
Cancer
Mathematical Model Captures Relationship between Speed and Surface in Cell Movement
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Biopharma Manufacturers Shouldn’t Rush When “Going Digital”
Bioprocessing
Separating Cells with Microfluidics
Trends for 2021
Beyond 2021: Cell Therapy Manufacturing Trends
Bioprocessing
Machine Learning for Better Bioprocess Data Analysis
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antisense
Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma
Drug Discovery
Novel Promising Anti-Fungal Compound Identified in Ant Nests
Cancer
Promising Triple Therapy Approach Identified for Renal Cell Carcinoma
Cancer
Mathematical Model Captures Relationship between Speed and Surface in Cell Movement
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
COVID-19 Candidates
COVID-19 Front Runner
COVID-19 Front Runner
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
COVID-19 Front Runner
Bharat Biotech and Ocugen – COVAXIN™
COVID-19 Front Runner
Gamaleya Research Institute of Epidemiology and Microbiology – Sputnik V
COVID-19 Front Runner
Humanigen – Lenzilumab
COVID-19 Front Runner
Sinopharm Group (China National Biotech Group, Beijing Institute of Biological Products) and Chinese Center for Disease Control and Prevention
COVID-19 Front Runner
Novavax – NVX-CoV2373
COVID-19 Front Runner
University of Oxford, AstraZeneca and partners – AZD1222 (formerly ChadOx1 nCoV-19)
COVID-19 Front Runner
Regeneron Pharmaceuticals – REGEN-COV2 (casirivimab and imdevimab)
COVID-19 Front Runner
Eli Lilly and AbCellera – Bamlanivimab (LY-CoV555)
COVID-19 Front Runner
CanSino Biologics – Ad5-nCoV
COVID-19 Front Runner
Gilead Sciences – Remdesivir (Veklury®, DESREM™)
COVID-19 Front Runner
Distributed Bio
COVID-19 Front Runner
Janssen Pharmaceutical Cos. (J&J) and BARDA – JNJ-78436735 (Ad26.COV2.S)
COVID-19 Front Runner
Moderna – mRNA-1273
COVID-19 Front Runner
Vir Biotechnology and Alnylam
COVID-19 Front Runner
Fujifilm Holdings and Zhejiang Hisun Pharmaceutical – Favipiravir
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
